These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12497882)

  • 1. [ACE-inhibitors, AT1 receptor antagonists and diastolic dysfunction].
    Metra M; Nodari S; Bordonali T; Cagnazzi E; Boldi E; Dei Cas L
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):53-8. PubMed ID: 12497882
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
    Sander GE; McKinnie JJ; Greenberg SS; Giles TD
    Prog Cardiovasc Dis; 1999; 41(4):265-300. PubMed ID: 10362349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP; Rumley A; Lowe GD; McMurray JJ
    Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.
    Healey JS; Morillo CA; Connolly SJ
    Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
    Ghanem FA; Movahed A
    Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic role of RAS blockade in chronic heart failure.
    Werner CM; Böhm M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):167-77. PubMed ID: 19124420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
    Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with ACE inhibitors and angiotensin-receptor blockers in heart failure.
    Scow DT; Smith EG; Shaughnessy AF
    Am Fam Physician; 2003 Nov; 68(9):1795-8. PubMed ID: 14620599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel imaging strategies for predicting remodeling and evolution of heart failure: targeting the Renin-Angiotensin system.
    Shirani J; Narula J; Eckelman WC; Dilsizian V
    Heart Fail Clin; 2006 Apr; 2(2):231-47. PubMed ID: 17386892
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?].
    Karlsen FM; Kamper AL
    Ugeskr Laeger; 2003 Oct; 165(42):4006-9. PubMed ID: 14610833
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment.
    Andersen NH; Mogensen CE
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):146-52. PubMed ID: 11881115
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of ACE inhibitors and angiotensin receptor blockers in the treatment and prevention of chronic heart failure].
    Kárpáti P
    Orv Hetil; 2005 May; 146(18):827-31. PubMed ID: 15926627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapies following heart failure and myocardial infarction(discussion)].
    Shimizu T; Komuro I; Hirayama H; Hiramitsu S; Shimizu K; Yoshida O
    Nihon Rinsho; 2002 Jun; 60(6):1235-50. PubMed ID: 12143782
    [No Abstract]   [Full Text] [Related]  

  • 14. ACE inhibitors or AT(1) receptor blockers in heart failure?
    Rydén L
    Eur Heart J; 1999 Sep; 20(18):1287-9. PubMed ID: 10462459
    [No Abstract]   [Full Text] [Related]  

  • 15. Are angiotensin-receptor blockers (ARBs) equivalent to or better than angiotensin-converting enzyme (ACE) inhibitors in the treatment of heart failure?
    Reigle J
    Crit Care Nurse; 2004 Dec; 24(6):67-9. PubMed ID: 15646090
    [No Abstract]   [Full Text] [Related]  

  • 16. [Converting enzyme inhibitors or AT1 receptor blockers].
    Trevethan Cravioto S
    Arch Cardiol Mex; 2001; 71 Suppl 1():S171-6. PubMed ID: 11565329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
    Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating diastolic heart failure: the role of ACE inhibitors.
    Bettencourt P
    Rev Port Cardiol; 1999 Sep; 18 Suppl 5():V101-6. PubMed ID: 10582470
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
    Azizi M
    Rev Prat; 2004 Jun; 54(11):1167-74. PubMed ID: 15496022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of angiotensin II receptor antagonists in the treatment of patients with chronic heart failure].
    Martynov AI; Vasiuk IuA; Krikunov PV; Khadzagova AB; Iushchuk EN; Sologub KN
    Ter Arkh; 2001; 73(8):84-8. PubMed ID: 11599279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.